Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-05-18T12:07:22.640Z Has data issue: false hasContentIssue false

The growth of vaccinia virus in the chorio-allantois of the developing chick embryo and the production of complement-fixing antigen and haemagglutinin

Published online by Cambridge University Press:  15 May 2009

H. B. Maitland
Affiliation:
Department of Bacteriology, University of Manchester
Barbara M. Tobin
Affiliation:
Department of Bacteriology, University of Manchester
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

1. Elementary body suspensions of vaccinia virus placed on the chorio-allantoic membrane of the developing chick embryo showed immediately an enhanced infectivity which may amount to a several-fold increase in titre.

2. In studying the growth curve of vaccinia virus in the chorio-allantois the distribution of virus between the liquid and the membrane had to be taken into account.

3. Some virus disappeared after inoculation, but this did not necessarily indicate a non-infective phase in a growth cycle.

4. Virus began to increase in 4–5 hr. and proceeded without stepwise increments, reaching a maximum in about 36 hr.

5. Haemagglutinin and complement-fixing ‘soluble’ antigen were formed during the growth of virus, and the titre of each was directly related to the amount of virus. They were detectable when the titre of virus reached respectively 106.5–10.70 and 105.5–106.0 pocks per ml.

6. Haemagglutinin may have been acting as a complement-fixing antigen.

7. Neither haemagglutination nor complement-fixation provided evidence for the occurrence of a non-infective phase of virus as part of a growth cycle.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1956

References

REFERENCES

Anderson, S. G. (1954). The growth curve of vaccinia virus on the chorio-allantois. Aust. J. exp. Biol. med. Sci. 32, 633.CrossRefGoogle Scholar
Briody, B. A. & Stannard, C. (1951). Studies on vaccinia virus. I. The development of haemagglutinating and infective particles in the chorio-allantois of the chick embryo. J. Immunol. 67, 403.CrossRefGoogle Scholar
Casals, J. (1949). Acetone-ether extracted antigens for complement fixation with certain neurotropic viruses. Proc. Soc. exp. Biol., N.Y., 70, 339.CrossRefGoogle ScholarPubMed
Forsyth, P. J., Cook, E. B. M. & Irons, J. V. (1954). The growth curve of vaccinia virus on the chorio-allantoic membrane of embryonated eggs. Bact. Proc. p. 89.Google Scholar
Hoagland, C. L., Smadel, H. E. & Rivers, T. M. (1940). Constituents of elementary bodies of vaccinia; certain basic analyses and observations on lipid components of the virus. J. exp. Med. 71, 737.CrossRefGoogle ScholarPubMed
Lépine, P., Wielgosz, G. & Reinie, L. (1951). Courbe de croissance du virus vaccinal dans le membrane chorio-allantoïdienne de l'œuf. Ann. Inst. Pasteur, 81, 77.Google Scholar
Macfarlane, M. G. & Salaman, M. H. (1938). The enzymic activity of vaccinial elementary bodies. Brit. J. exp. Path. 19, 184.Google Scholar
Stone, J. D. & Burnet, F. M. (1946). Production of vaccinia haemagglutinin in rabbit skin. Aust. J. exp. Biol. med. Sci. 24, 9.CrossRefGoogle ScholarPubMed